| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |